Medindia LOGIN REGISTER
Medindia

Black People With COVID-19 More Likely to Develop Diabetic Ketoacidosis

by Colleen Fleiss on Jan 9 2021 2:31 AM

Black people with type 1 diabetes and COVID-19 are four times more likely to be hospitalized for diabetic ketoacidosis.

Black People With COVID-19 More Likely to Develop Diabetic Ketoacidosis
Black people with type 1 diabetes and COVID-19 are four times more likely to be hospitalized for diabetic ketoacidosis, stated a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Health //disparities refer to unequal health status or health care between groups of people due to differences in their background, physical traits or their environment. These differences include race/ethnicity, country of origin, sex, income and disability.

Minorities are disproportionately affected by diabetes and COVID-19 and are more likely to develop serious complications like diabetic ketoacidosis, a condition that occurs when your body produces high levels of blood acids.

"This is the first major study to examine racial-ethnic inequities for people with type 1 diabetes and COVID-19 that are brought on by structural and systemic racism," said study author Osagie Ebekozien, M.D., M.P.H., of the T1D Exchange in Boston, Mass.

"We used a diverse cohort of patients with type 1 diabetes and found there is a significantly increased risk of worse outcomes for Black and Hispanic patients with COVID-19 and diabetes."

The researchers analyzed data from 180 people with type 1 diabetes and COVID-19 from 52 clinical sites in the United States. The study found Black patients were four times more likely to be hospitalized for diabetic ketoacidosis than Caucasians.

Black and Hispanic patients were also less likely to use diabetes technology like continuous glucose monitors (CGMs) and insulin pumps, and they had worse glycemic control than Caucasian patients.

Advertisement
"Our findings of troubling and significant inequities call for urgent and targeted interventions, such as culturally appropriate diabetic ketoacidosis awareness campaigns, increased continuous glucose monitoring coverage for minority patients and health care provider participation in a Quality Improvement Collaborative," Ebekozien said.

Source-Eurekalert


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education